• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Hard Look at Cardiac Safety with Dopamine Agonists in Endocrinology.

作者信息

Daly Adrian F, Beckers Albert

机构信息

Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Domaine Universtaire Sart-Tilman, 4000 Liège, Belgium.

出版信息

J Clin Endocrinol Metab. 2021 May 13;106(6):e2452-e2454. doi: 10.1210/clinem/dgab073.

DOI:10.1210/clinem/dgab073
PMID:33550413
Abstract
摘要

相似文献

1
A Hard Look at Cardiac Safety with Dopamine Agonists in Endocrinology.深入审视内分泌学中多巴胺激动剂的心脏安全性
J Clin Endocrinol Metab. 2021 May 13;106(6):e2452-e2454. doi: 10.1210/clinem/dgab073.
2
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.多巴胺激动剂、多普勒检查与疑虑：卡麦角林相关的心脏瓣膜病
Intern Med J. 2009 Apr;39(4):213-5. doi: 10.1111/j.1445-5994.2009.01916.x.
3
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.多巴胺激动剂在治疗高催乳素血症及抑制泌乳方面耐受性概况的比较性综述。
Drug Saf. 1996 Apr;14(4):228-38. doi: 10.2165/00002018-199614040-00003.
4
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.卡麦角林对泌乳素瘤和特发性高泌乳素血症患者瓣膜状态影响的前瞻性长期研究。
Endocrine. 2017 Jan;55(1):239-245. doi: 10.1007/s12020-016-1120-5. Epub 2016 Oct 5.
5
Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study.卡麦角林治疗高催乳素血症相关的心脏瓣膜异常：CATCH 研究。
BMC Endocr Disord. 2020 Feb 19;20(1):25. doi: 10.1186/s12902-020-0507-8.
6
Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.卡麦角林与高泌乳素血症：新制剂。比溴隐亭更好。
Prescrire Int. 2000 Feb;9(45):195-7.
7
AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease.美国临床内分泌医师协会/美国内分泌学会疾病状态临床综述：多巴胺激动剂治疗高催乳素血症与心脏瓣膜病风险
Endocr Pract. 2014 Jun;20(6):608-16. doi: 10.4158/EP14148.RA.
8
Cardiopulmonary complications of ergot-derivative dopamine agonists.麦角衍生物多巴胺激动剂的心肺并发症
J Clin Psychiatry. 2004 Oct;65(10):1429-30; author reply 1430. doi: 10.4088/jcp.v65n1020b.
9
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.帕金森病中多巴胺激动剂治疗引发的心脏瓣膜纤维化反应。
Lancet Neurol. 2007 Sep;6(9):826-9. doi: 10.1016/S1474-4422(07)70218-1.
10
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.卡麦角林治疗高催乳素血症：455例患者的研究
J Clin Endocrinol Metab. 1999 Jul;84(7):2518-22. doi: 10.1210/jcem.84.7.5810.

引用本文的文献

1
Hyperprolactinemia in women: treatment.女性高催乳素血症：治疗
Rev Bras Ginecol Obstet. 2024 Apr 25;46. doi: 10.61622/rbgo/2024FPS05. eCollection 2024.
2
Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM).女性高泌乳素血症的治疗：巴西妇科和产科协会联合会（Febrasgo）和巴西内分泌与代谢学会（SBEM）的立场声明。
Arch Endocrinol Metab. 2024 Apr 5;68:e230504. doi: 10.20945/2359-4292-2023-0504.
3
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the (AIP) gene.
与 AIP 基因胚系致病性变异相关的泌乳素瘤的临床和治疗特征。
Front Endocrinol (Lausanne). 2023 Aug 29;14:1242588. doi: 10.3389/fendo.2023.1242588. eCollection 2023.
4
Current and Emerging Medical Therapies in Pituitary Tumors.垂体瘤的当前及新兴医学治疗方法
J Clin Med. 2022 Feb 12;11(4):955. doi: 10.3390/jcm11040955.